Impacts of Patent Expiry on Daily Cost of Pharmaceutical Treatments in Eight OECD Countries, 2004

Impacts of Patent Expiry on Daily Cost of Pharmaceutical Treatments in Eight OECD Countries, 2004–2010

Published:2016-01-18 Issue:2 Volume:23 Page:125-147
ISSN:1357-1516
Container-title:International Journal of the Economics of Business
language:en
Short-container-title:International Journal of the Economics of Business

Author:

Berndt Ernst R.,Dubois Pierre

Funder

PFIZER INC.

Publisher

Informa UK Limited

Subject

Economics and Econometrics,Business, Management and Accounting (miscellaneous)

Link

http://www.tandfonline.com/doi/pdf/10.1080/13571516.2015.1122969

Reference33 articles.

1. Appelt, Silvia. 2011. Authorized Generic Entry prior to Patent Expiry: Reassessing Incentives for Independent Generic Entry », University of Munich, forthcoming Review of Economics and Statistics

2. UNEQUALLY SPACED PANEL DATA REGRESSIONS WITH AR(1) DISTURBANCES

3. Brand Loyalty, Generic Entry and Price Competition in Pharmaceuticals in the Quarter Century after the 1984 Waxman-Hatch Legislation

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The Allocation of the Economic Value of Second-Generation Antipsychotics Over the Product Life Cycle: The Case of Risperidone in Sweden and the United Kingdom;Value in Health;2023-03

2. What is the impact of intellectual property rules on access to medicines? A systematic review;Globalization and Health;2022-04-15

3. Cost-Effectiveness Analysis of Direct Oral Anticoagulants Vs. Vitamin K Antagonists in the Elderly With Atrial Fibrillation: Insights From the Evidence in a Real-World Setting;Frontiers in Cardiovascular Medicine;2021-06-29

4. The unexpected consequences of generic entry;Journal of Health Economics;2019-12

5. Four Facts Concerning Competition in US Generic Prescription Drug Markets;International Journal of the Economics of Business;2019-09-05